LEVIMMUNE
DEAD

Serial Number

88751609

Owner

CytoDyn Inc.

Attorney

Jared M. Barrett

Filing Date

Jan 8, 2020

Add to watchlist:

No watchlists yet
View on USPTO

LEVIMMUNE Trademark

Serial Number: 88751609

LEVIMMUNE is a trademark filed by CytoDyn Inc. on January 8, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

CytoDyn Inc. (14 trademarks)

1111 Main Street, Suite 660
Vancouver, WA 98660

Entity Type: 03

Trademark Details

Filing Date

January 8, 2020

Registration Date

Not Registered

Published for Opposition

June 9, 2020

Goods & Services

Therapeutic preparations, namely, therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19, and therapeutic preparations for the prevention of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor

Providing health and medical information, and providing health and medical information in the nature of providing a website featuring information in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; providing a website featuring medical information; providing a website featuring medical information in the field of antibodies for use in targeting the CCR5 cell receptor; medical analysis services, namely, medical analysis services in the field of antibodies for use in targeting the CCR5 cell receptor, and medical analysis services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19

Scientific research consulting services, namely, scientific research consulting services in the field of immunology, and scientific research consulting services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services, and medical research services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services in the field of antibodies for use in targeting the CCR5 cell receptor

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Mar 7, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 7, 2022 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 15, 2021 EXRA
SOU EXTENSION 2 GRANTED
Jul 13, 2021 EX2G
SOU EXTENSION 2 FILED
Jul 13, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 13, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 12, 2021 EXRA
SOU EXTENSION 1 GRANTED
Jan 8, 2021 EX1G
SOU EXTENSION 1 FILED
Jan 8, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 8, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 4, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 9, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 9, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 20, 2020 NONP
ASSIGNED TO LIE
May 4, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 24, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 24, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 24, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 24, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 24, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 22, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 21, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 21, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 28, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 28, 2020 GNRT
NON-FINAL ACTION WRITTEN
Mar 28, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 26, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 13, 2020 NWOS
NEW APPLICATION ENTERED
Jan 11, 2020 NWAP